Valadao vote on Inflation Reduction Act questioned
I applaud the recent passage of the Inflation Reduction Act, which takes on Big Pharma and the drug industry. Thanks to this bill, Medicare can negotiate the prices of some of the most expensive prescription drugs starting in 2026.
That is going to save seniors money — as many as 48 million Americans who rely on Medicare for prescription drug coverage will have more money in their pockets. Drug companies that refuse to negotiate will be penalized — as they should be.
The Inflation Reduction Act also curbs costs for seniors by capping the cost of insulin at $35 per month and ensuring these individuals pay no more than $2,000 out-of-pocket for prescription drugs annually.
Given all those benefits, why did Congressman David Valadao vote against helping seniors and holding drug companies accountable?
This letter to the editor originally ran in The Sentinel.